Nestle is debuting a new infant formula containing a proprietary blend in Hong Kong in November 2023. The blend is said to be an “all-round” nutrition for supporting multiple growth areas, including digestive, bone, and cognitive health.
Australia’s Therapeutic Goods Administration (TGA) has approved for the first time the use of 3-fucosyllactose (3-FL) as a complementary medicine ingredient in listed medicines, such as dietary supplements.
